가미강활산(加味羌活散)이 집먼지 진드기 추출물로 유도된 NC/Nga mouse의 아토피 피부염에 미치는 영향 = Effect of Kami-kanghwalsan (KKHS) on Atopic Dermatitis-like Skin Lesions Induced in NC/Nga Mouse by Mite Antigen Stimulation

다국어 초록 (Multilingual Abstract)

Objectives The purpose of this study is to investigate the effect of KKHS on atopic dermatitis in an in-vivo experiment using an NC/Nga atopic dermatitis mouse, which has histological and clinical similarities to this condition in humans. Methods To investigate the effect of KKHS on atopic dermatitis (AD), we evaluated atopic dermatitis-like skin lesions by clinical skin index and analyzed immunological parameters in peripheral blood mononuclear cells(PBMCs), splenocytes, draining lymph node(DLN) and performed skin histology in ears and dorsal skin of atopic dermatitis of NC/Nga mouse in vivo. Results In vivo, clinical skin severity score was significantly lower in the KKHS group than in the control group. IgE, IL-6, TNF-${\alpha}$, IgM, IgG2a and IgG2b levels in serum decreased remarkably in the KKHS group than in the control group, and the level of IFN-${\gamma}$ production which is secreted from Th1 cell was increased by KKHS. After this experiment we analyzed immunological cells ($CD3^+$, $CD19^+$, $CD4^+$, $CD8^+$, $CD3^+CD69^+$, $CD4^+CD25^+$ and $CD49b^+$) by flow cytometry. It results that the total absolute number of $CD3^+$, $CD19^+$, $CD4^+$ and $CD8^+$ cells were recovered as much as normal state, and the level of $CD3^+CD69^+$ in isolated DLN and PBMCs were significantly decreased, and total absolute number of $Gr-1^+$, $CD11b^+$ and $CD3^+$ in dorsal skin of NC/Nga mouse were decreased by KKHS. We analyzed ear, DLN, and neck-back skin after biopsy and dyeing by hematoxyline/eosin(H&E), toluidine staining (mast cells marker). KKHS were very effective to the histological symptoms which are in dermal and epidermal thickening, hyperkeratosis and inflammatory cell infiltration. Ear thickness was significantly decreased compared with the control group and the size of inflammatory lymphocytes cells (ILC) and plasma cells (PC) in DLN were also decreased. Conclusions KKHS on atopic dermatitis in an in-vivo experiment using an NC/Nga atopic dermatitis mouse was very effectiveness to the atopy dermatitis treatment.

참고문헌 (Reference)

1 王肯堂, "六科准繩(兒科)" 新文豊出版股份有限公司 256-, 1968

2 대한피부과학회, "피부과학" 여문각 133-138, 1994

3 오재원, "집먼지진드기에 감작된 아토피 및 비아토피 개체에서 Derp Ⅰ 및 면역변환제의 자극에 의한 T 림프절구의 Interleukin-4와 Interferon-γ 생성의 차이" 19 (19): 548-556, 1999

4 김정원, "알레르기 및 면역학적 관점에서의 아토피피부염" 41 (41): 687-689, 2003

5 김정희, "아토피피부염의 최신지견" 대한 소아알레르기 호흡기학회 14 (14): 12-23, 2004

6 공남미, "아토피피부염의 양․한방적 고찰" 12 : 241-253, 1999

7 노건웅, "아토피피부염의 감마 인터페론 치료" 7 (7): 239-247, 1998

8 안필수, "아토피피부염에서의 재조합 감마 인터페론 치료효과" 16 (16): 291-298, 1996

9 성현철, "아토피피부염에서 임상적 중등도에 따른 알레르기 검사소견" 44 (44): 1051-1057, 2006

10 임정우, "아토피피부염 환자의 발병과 치료에 대한 실태 조사" 대한 소아알레르기 호흡기학회 15 (15): 44-52, 2005

11 박용민, "아토피피부염 병태생리에 대한 최신 지견" 대한 소아알레르기 호흡기학회 16 (16): 189-196, 2006

12 조상헌, "아토피 환자에서의 IgE 항체 생성 조절기전. 말초혈액 림프절구의 IL-4, IFN-γ 생성의 불균형" 15 (15): 205-215, 1995

13 조상헌, "아토피 환자에서의 IgE 항체 생성 조절기전. 말초혈액 림프절구의 IL-4, IFN-γ 생성의 불균형" 15 (15): 205-215, 1995

14 이상현, "아토피 피부염 치료 처방에 대한 方劑學的 考察" 대한한방안이비인후피부과학회 19 (19): 103-117, 2006

15 홍창의, "소아과학" 대한교과서주식회사 1207-1211, 2005

16 에카자와 센로우, "소아 피부과학" 고려의학 20-30, 2005

17 김광혁, "세포분자 면역학" 정문각 298-33, 1998

18 Janeway, Travers, "면역생물학" 라이프사이언스 361-, 2005

19 김덕곤, "동의소아과학" 정담 660-664, 2002

20 李梃, "醫學入門" 翰成社 699-721, 1984

21 박성희, "脾虛蘊濕方이 아토피 피부염 유발 NC/Nga 생쥐의 혈액내 면역 관련 인자에 미치는 영향" 대한동의병리학회 21 (21): 849-855, 2007

22 曹孝忠, "聖濟總錄" 新文豊出版社 1439-1440, 1978

23 홍원식, "精巧皇帝內徑素問" 동양의학연구원출판부 72-80, 1985

24 진경선, "淸上防風湯의 아토피성 알레르기 반응 조절 효과" 18 (18): 61-76, 2004

25 許浚, "東醫寶鑑" 남산당 648-, 1986

26 康秉秀, "本草學" 永林社 142-, 1991

27 巢元方, "巢氏諸病源候論" 大星文化社 251-253, 1992

28 陳實功, "外科正宗" 人民衛生出版社 269-, 1983

29 김홍배, "升麻葛根湯의 항히스타민 효과 및 IL-4와 GM-CSF 발현에 미치는 영향" 대한한방소아과학회 20 (20): 69-83, 2006

30 유한정, "內消和中湯加味方이 아토피피부염 환아의 혈중 Cytokine 분비에 미치는 영향" 대한한방소아과학회 20 (20): 15-29, 2006

31 Kay AB, "Overview of allergy and allergic disease:with a view to the future" 56 : 843-864, 2000

32 .Ohmen JD, "Overexpression of IL-10 in atopic dermatitis" 154 : 1956-1963, 1995

33 Skehan P, "New colorimetric cytotoxicity assay for anticancer drug screening" 82 (82): 1107-1111, 1990

34 Foster PS, "Interleukin-4, -5, and -13. emerging therapeutic targets in allergic disease" 94 : 253-264, 2002

35 김세종, "IMMUNOLOGY" 고려의학 1-65, 1994

36 Konishi H, "IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions" 99 (99): 11340-11345, 2002

37 Renz H, "Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma" 99 : 403-408, 1992

38 Inagaki N, "Drugs for the treatment of allergic diseases" 86 : 275-280, 2001

39 Esnault S, "Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-γ) in peripheral blood mononuclear cells (PBMC) from atopic patients" 104 : 111-118, 1996

40 Matsuda H, "Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mouse" 9 (9): 461-466, 1997

41 Halbert AR, "Atopic dermatitis:is it an allergic disease" 33 (33): 1008-1018, 1995

42 Shiohara T, "Animal models for atopic dermatitis:are they relevant to human disease" 36 (36): 1-9, 2004

43 Matsuoka H, "A mouse model of the atopic eczema/dermatitis syndrome by repeated" 6 : 1616-1622, 2006

44 Yamamoto M, "A Novel Atopic Dermatitis Model Induced by Topical Application with Dermatophagoides Farinae Extract in NC/Nga mouse" 56 : 139-148, 2007